伏沙诺吉哌在一名患有STAT3高免疫球蛋白E综合征和终末期肾病的儿科患者中成功用于治疗罕见的高度耐药皮肤镰刀菌病。
Successful Use of Fosmanogepix for Treatment of Rare Highly Resistant Cutaneous Fusariosis in a Pediatric Patient With STAT3 Hyper-Immunoglobulin E Syndrome and End-Stage Kidney Disease.
作者信息
Goggin Kathryn P, Londeree Jackson, Freeman Alexandra F, Garro Rouba, George Roshan P
机构信息
Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
Division of Nephrology, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
出版信息
Open Forum Infect Dis. 2023 May 23;10(6):ofad285. doi: 10.1093/ofid/ofad285. eCollection 2023 Jun.
We describe the successful use of the novel antifungal drug fosmanogepix to treat a chronic case of multidrug-resistant cutaneous infection in a pediatric patient with STAT3 hyper-IgE syndrome and end-stage kidney disease on peritoneal dialysis.
我们描述了新型抗真菌药物伏沙诺吉哌用于治疗一名患有信号转导和转录激活因子3（STAT3）高免疫球蛋白E综合征及终末期肾病且正在进行腹膜透析的儿科患者的耐多药皮肤慢性感染的成功案例。
Zotero 插件